Nanexa AB (Sweden) Today
| NANEXA Stock | 1.27 0.05 3.79% |
Performance0 of 100
| Odds Of DistressLess than 23
|
Nanexa AB is trading at 1.27 as of the 23rd of November 2024, a 3.79 percent decrease since the beginning of the trading day. The stock's open price was 1.32. Nanexa AB has about a 23 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Nanexa AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of October 2024 and ending today, the 23rd of November 2024. Click here to learn more.
Moving together with Nanexa Stock
Moving against Nanexa Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Nanexa Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Nanexa AB's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Nanexa AB or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers-Specialty & Generic, Healthcare (View all Sectors) |
Nanexa AB (NANEXA) is traded on Stockholm Exchange in Sweden and employs 19 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 244 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Nanexa AB's market, we take the total number of its shares issued and multiply it by Nanexa AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Nanexa AB operates under Healthcare sector and is part of Drug Manufacturers-Specialty & Generic industry. The entity has 60.7 M outstanding shares.
Nanexa AB generates negative cash flow from operations
Check Nanexa AB Probability Of Bankruptcy
Ownership AllocationNanexa AB maintains a total of 60.7 Million outstanding shares. Nanexa AB holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Nanexa Ownership Details
Nanexa AB Risk Profiles
Although Nanexa AB's alpha and beta are two of the key measurements used to evaluate Nanexa AB's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.27 | |||
| Standard Deviation | 4.65 | |||
| Variance | 21.6 | |||
| Risk Adjusted Performance | (0.05) |
Nanexa Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Nanexa AB without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Correlation Analysis Now
Correlation AnalysisReduce portfolio risk simply by holding instruments which are not perfectly correlated |
| All Next | Launch Module |
Nanexa AB Corporate Management
Elected by the shareholders, the Nanexa AB's board of directors comprises two types of representatives: Nanexa AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nanexa. The board's role is to monitor Nanexa AB's management team and ensure that shareholders' interests are well served. Nanexa AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nanexa AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Otto MSc | Director Director | Profile | |
| Marten Rooth | Head CoFounder | Profile | |
| David Westberg | Chief Officer | Profile | |
| Anders Johansson | CoFounder Property | Profile | |
| Mikael Asp | Head Expert | Profile | |
| Bengt MSc | Medical Director | Profile | |
| Joel Hellrup | Head RD | Profile |
Other Information on Investing in Nanexa Stock
Nanexa AB financial ratios help investors to determine whether Nanexa Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nanexa with respect to the benefits of owning Nanexa AB security.